Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (12952)	9/29/2003 1:07:26 AM
From: Joe Krupa	Read Replies (4) \| Respond to of 14101

Jim, here is an interesting article on PENNSAID that I had sent to me. It's written by Dr. Ken Walker who writes a syndicated column under the pseudonym Dr. W. Gifford Jones. www3.sympatico.ca It appears that his columns are syndicated in up to 200 newspapers, though I have not been able to find an on-line version of the article. Dr. Ken Walker is a Toronto based physician and graduate of Harvard Medical School. 50plus.com FYI, joe

To: axial who wrote (12952)	9/30/2003 1:00:03 PM
From: VAUGHN	Read Replies (2) \| Respond to of 14101

Hello Jim "I believe that's true, not because WF10 would act against the coronavirus specifically, but because of WF10's ability to restore proper immune signaling." In that regard, I also have to wonder if WF10 might help with certain forms of Arthritis which are believed to be caused by the body's immune system reacting to certain viruses. I have Synovitis in my knees and Ostio. in my hands and would love to see Dimethaid take a look at treating these forms of Arthritis. Treating/curing these diseases rather than simply killing the pain (Pensaid) would offer far more freedom and profit potential to WF10 than just HIV, etc. Regards Vaughn